NEW YORK (GenomeWeb News) — German biotech company Brain AG and Genencor will collaborate to use metagenomics and metabolic pathway engineering to develop enzymes and biosynthetic pathways for use in developing products that could be used to replace petrochemicals in products such as biofuels, plastics, rubber, adhesives, and cosmetics, Genencor said today.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.